
Merit Medical Systems, Inc.
MMSI
Updated: 23/09/2026, 03:39:47
Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.
No summaries found.
- Share price
- $87.26
- Market cap
- $5.21B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Martha Goldberg Aronson
- Employees
- 7,500
- IPO date
- 14/05/1990
- Beta
- 0.492
- Last dividend
- $0.00
- Day range
- $85.51 – $87.79
- 52-week range
- $59.74 – $94.75
- 1-day performance
- 2.07%
- 1-year performance
- 46.07%
- Current drawdown (1Y)
- -7.91%
- CIK
- 0000856982
- CUSIP
- 589889104
- ISIN
- US5898891040
- Created
- 07/12/2025, 05:17:21
- Last update
- 23/09/2026, 03:39:47
Track Merit Medical Systems, Inc. with an AI analyst
See which prediction-market events move MMSI, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Is the Options Market Predicting a Spike in Merit Medical Systems Stock?
Zacks Investment Research • STOCK • 08/06/2026, 15:16:08
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
Zacks Investment Research • STOCK • 08/06/2026, 14:55:54
Merit Medical Systems, Inc. (MMSI) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha • STOCK • 08/06/2026, 14:08:30
Here's Why Merit Medical (MMSI) is a Strong Value Stock
Zacks Investment Research • STOCK • 02/06/2026, 12:41:09
Merit Medical Shareholders Elect Scott R. Ward to Board of Directors
GlobeNewsWire • STOCK • 19/05/2026, 11:15:00
Merit Medical Systems, Inc. (MMSI) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha • STOCK • 12/05/2026, 22:40:43
Merit Medical Systems: Creating More Growth Engines (Rating Upgrade)
Seeking Alpha • STOCK • 02/05/2026, 04:21:06
Merit Medical Q1 Earnings & Revenues Beat Estimates, Sales View Up
Zacks Investment Research • STOCK • 01/05/2026, 13:15:43
Merit Medical Systems, Inc. (MMSI) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 01/05/2026, 05:31:33
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
Zacks Investment Research • STOCK • 15/04/2026, 15:45:33
MMSI Expands Oncology Offering With View Point Medical Acquisition
Zacks Investment Research • STOCK • 02/04/2026, 13:51:06
MMSI Launches Resilience TTS Stent for Esophageal Fistulas, Strictures
Zacks Investment Research • STOCK • 18/03/2026, 12:01:15